Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
t-cell symbols : Tcrx save search
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies- Completion of facility supports upcoming clinical milestones including expected multiple fourth quarter IND filings -
Published: 2021-12-02 (Crawled : 13:30) - biospace.com/
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $62.94 0.02% 0.0% 1M
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan milestone t-cell
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies
Published: 2021-12-02 (Crawled : 12:30) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: -10.66%
H: 0.0%
C: 0.0%
BXP 4 | $62.94 0.02% 0.0% 1M
|
Finance
|
| O: -2.97%
H: 5.04%
C: 4.17%
therapeutics scan therapy t-cell
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit
Published: 2021-07-21 (Crawled : 12:00) - globenewswire.com
TCRX | News 3 d | $7.39 1.79% 1.76% 91K
|
Professional, Scientific, and T...
|
| O: 2.73%
H: 0.0%
C: -9.54%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 0.55%
H: 1.65%
C: 1.1%
covid disease media infectious disease therapy t-cell
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
ILAG | $0.51 6.03% 29.06% 430K
|
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.